JP2021512143A5 - - Google Patents
Info
- Publication number
- JP2021512143A5 JP2021512143A5 JP2020560615A JP2020560615A JP2021512143A5 JP 2021512143 A5 JP2021512143 A5 JP 2021512143A5 JP 2020560615 A JP2020560615 A JP 2020560615A JP 2020560615 A JP2020560615 A JP 2020560615A JP 2021512143 A5 JP2021512143 A5 JP 2021512143A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- amino
- carboxamide
- acetyl
- pyridine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023191935A JP2024023271A (ja) | 2018-01-26 | 2023-11-10 | 化合物 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1801355.7 | 2018-01-26 | ||
| GBGB1801355.7A GB201801355D0 (en) | 2018-01-26 | 2018-01-26 | Compounds |
| PCT/GB2019/050209 WO2019145726A1 (en) | 2018-01-26 | 2019-01-25 | Compounds |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023191935A Division JP2024023271A (ja) | 2018-01-26 | 2023-11-10 | 化合物 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2021512143A JP2021512143A (ja) | 2021-05-13 |
| JP2021512143A5 true JP2021512143A5 (enExample) | 2022-02-02 |
Family
ID=61558141
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020560615A Pending JP2021512143A (ja) | 2018-01-26 | 2019-01-25 | 化合物 |
| JP2023191935A Pending JP2024023271A (ja) | 2018-01-26 | 2023-11-10 | 化合物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023191935A Pending JP2024023271A (ja) | 2018-01-26 | 2023-11-10 | 化合物 |
Country Status (32)
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201801355D0 (en) | 2018-01-26 | 2018-03-14 | Enterprise Therapeutics Ltd | Compounds |
| GB201908453D0 (en) * | 2019-06-12 | 2019-07-24 | Enterprise Therapeutics Ltd | Compounds for treating respiratory disease |
| CR20220006A (es) * | 2019-06-12 | 2022-06-06 | Tmem16A Ltd | Compuestos para tratar enfermedad respiratoria |
| KR20220063162A (ko) * | 2019-07-24 | 2022-05-17 | 티엠이엠16에이 리미티드 | 호흡기 병태 치료에 사용하기 위한 tmem16a 조절제로서의 피리딘 유도체 |
| GB201910608D0 (en) * | 2019-07-24 | 2019-09-04 | Enterprise Therapeutics Ltd | Compounds |
| GB201910666D0 (en) * | 2019-07-25 | 2019-09-11 | Enterprise Therapeutics Ltd | Novel form of compounds |
| GB201910664D0 (en) * | 2019-07-25 | 2019-09-11 | Enterprise Therapeutics Ltd | Novel forms of compound |
| GB201910665D0 (en) * | 2019-07-25 | 2019-09-11 | Enterprise Therapeutics Ltd | Novel form of compounds |
| AU2020338971B2 (en) * | 2019-08-28 | 2023-11-23 | Novartis Ag | Substituted 1,3-phenyl heteroaryl derivatives and their use in the treatment of disease |
| WO2021117767A1 (ja) * | 2019-12-10 | 2021-06-17 | 田辺三菱製薬株式会社 | 含窒素ヘテロアリールカルボキサミド酢酸誘導体の製造方法 |
| EP4143196A4 (en) | 2020-04-29 | 2024-04-17 | Relay Therapeutics, Inc. | PI3K-A INHIBITORS AND METHODS OF USE THEREOF |
| JP2023533016A (ja) | 2020-07-11 | 2023-08-01 | ファイザー・インク | 抗ウイルス性ヘテロアリールケトン誘導体 |
| US20230271918A1 (en) * | 2020-08-10 | 2023-08-31 | Dana-Farber Cancer Institute, Inc. | Substituted 3-amino-4-methylbenzenesulfonamides as small molecule inhibitors of ubiquitin-specific protease 28 |
| US11351149B2 (en) | 2020-09-03 | 2022-06-07 | Pfizer Inc. | Nitrile-containing antiviral compounds |
| EP4259607A1 (en) * | 2020-12-11 | 2023-10-18 | Tmem16A Limited | Benzimidazole derivatives for treating respiratory disease |
| WO2022150173A1 (en) | 2021-01-06 | 2022-07-14 | AbbVie Global Enterprises Ltd. | Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use |
| WO2022150174A1 (en) | 2021-01-06 | 2022-07-14 | AbbVie Global Enterprises Ltd. | Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use |
| CN120476113A (zh) * | 2022-12-20 | 2025-08-12 | 杭州中美华东制药有限公司 | 具有sting抑制作用的含肟化合物及其药物组合物和用途 |
| WO2025106788A1 (en) * | 2023-11-15 | 2025-05-22 | Relay Therapeutics, Inc. | PI3Kα INHIBITORS AND METHODS OF MAKING AND USING THE SAME |
Family Cites Families (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE59106766D1 (de) | 1990-11-19 | 1995-11-30 | Christ Ag | Verfahren und Einrichtung zur Entsalzung von wässrigen Flüssigkeiten. |
| US6388054B1 (en) | 1998-08-20 | 2002-05-14 | John M. Stewart | Anti-cancer compounds |
| TWI243164B (en) | 2001-02-13 | 2005-11-11 | Aventis Pharma Gmbh | Acylated indanyl amines and their use as pharmaceuticals |
| TWI239942B (en) * | 2001-06-11 | 2005-09-21 | Dainippon Pharmaceutical Co | N-arylphenylacetamide derivative and pharmaceutical composition containing the same |
| GB0129267D0 (en) | 2001-12-06 | 2002-01-23 | Syngenta Ltd | Fungicides |
| JPWO2004011430A1 (ja) * | 2002-07-25 | 2005-11-24 | アステラス製薬株式会社 | ナトリウムチャネル阻害剤 |
| WO2004035545A2 (en) | 2002-10-18 | 2004-04-29 | E.I. Du Pont De Nemours And Company | Azolecarboxamide herbicides |
| WO2004106324A1 (en) * | 2003-05-27 | 2004-12-09 | E.I. Dupont De Nemours And Company | Azolecarboxamide herbicides |
| CN100545161C (zh) * | 2003-08-15 | 2009-09-30 | 中国科学院上海药物研究所 | 一类杂环衍生物、制备方法及其用途 |
| US20060069132A1 (en) * | 2004-04-07 | 2006-03-30 | Armel Gregory R | Azolecarboxamide herbicides |
| US8698604B2 (en) * | 2005-04-25 | 2014-04-15 | Lg Electronics Inc. | Reader control system |
| US7754717B2 (en) * | 2005-08-15 | 2010-07-13 | Amgen Inc. | Bis-aryl amide compounds and methods of use |
| CA2658362A1 (en) * | 2006-06-29 | 2008-01-03 | Alantos Pharmaceuticals Holding, Inc. | Metalloprotease inhibitors |
| EP2072501A1 (en) * | 2007-12-21 | 2009-06-24 | Bayer CropScience AG | Aminobenzamide derivatives as useful agents for controlling animal parasites |
| WO2009086303A2 (en) * | 2007-12-21 | 2009-07-09 | University Of Rochester | Method for altering the lifespan of eukaryotic organisms |
| PT2303270T (pt) | 2008-05-05 | 2017-08-25 | Sanofi Sa | Derivados fundidos do ácido ciclopentanocarboxílico substituídos por acilamino e sua utilização como produtos farmacêuticos |
| WO2009155565A1 (en) * | 2008-06-20 | 2009-12-23 | Genentech, Inc. | Triazolopyridine jak inhibitor compounds and methods |
| WO2010036316A1 (en) | 2008-09-24 | 2010-04-01 | Yangbo Feng | Urea and carbamate compounds and analogs as kinase inhibitors |
| EP2184273A1 (de) * | 2008-11-05 | 2010-05-12 | Bayer CropScience AG | Halogen-substituierte Verbindungen als Pestizide |
| WO2013033620A1 (en) | 2011-09-01 | 2013-03-07 | Irm Llc | Compounds and compositions as pdgfr kinase inhibitors |
| US8883819B2 (en) * | 2011-09-01 | 2014-11-11 | Irm Llc | Bicyclic heterocycle derivatives for the treatment of pulmonary arterial hypertension |
| US9452973B2 (en) | 2012-05-04 | 2016-09-27 | The United States Of America, As Represented By The Secretary Department Of Health And Human Services | Modulators of the relaxin receptor 1 |
| WO2014181287A1 (en) | 2013-05-09 | 2014-11-13 | Piramal Enterprises Limited | Heterocyclyl compounds and uses thereof |
| US9688637B2 (en) * | 2014-08-21 | 2017-06-27 | Northwestern Universtiy | 3-amidobenzamides and uses thereof for increasing cellular levels of A3G and other A3 family members |
| JP6621477B2 (ja) | 2014-12-18 | 2019-12-18 | ファイザー・インク | ピリミジンおよびトリアジン誘導体ならびにａｘｌ阻害薬としてのそれらの使用 |
| WO2017083971A1 (en) * | 2015-11-16 | 2017-05-26 | University Of Manitoba | Compositions and methods for treatment of influenza |
| GB201610854D0 (en) | 2016-06-21 | 2016-08-03 | Entpr Therapeutics Ltd | Compounds |
| GB201619694D0 (en) | 2016-11-22 | 2017-01-04 | Entpr Therapeutics Ltd | Compounds |
| GB201801355D0 (en) | 2018-01-26 | 2018-03-14 | Enterprise Therapeutics Ltd | Compounds |
| US20200361871A1 (en) | 2018-01-26 | 2020-11-19 | Enterprise Therapeutics Ltd. | Compounds |
| GB201910665D0 (en) | 2019-07-25 | 2019-09-11 | Enterprise Therapeutics Ltd | Novel form of compounds |
-
2018
- 2018-01-26 GB GBGB1801355.7A patent/GB201801355D0/en not_active Ceased
-
2019
- 2019-01-25 CR CR20200373A patent/CR20200373A/es unknown
- 2019-01-25 HU HUE19702958A patent/HUE061394T2/hu unknown
- 2019-01-25 IL IL276034A patent/IL276034B2/en unknown
- 2019-01-25 GB GB2013290.8A patent/GB2583882B/en active Active
- 2019-01-25 BR BR112020015169-6A patent/BR112020015169A2/pt unknown
- 2019-01-25 KR KR1020207020956A patent/KR102827138B1/ko active Active
- 2019-01-25 CN CN201980010318.9A patent/CN111683926B/zh active Active
- 2019-01-25 AU AU2019213211A patent/AU2019213211B2/en active Active
- 2019-01-25 HR HRP20230294TT patent/HRP20230294T1/hr unknown
- 2019-01-25 JP JP2020560615A patent/JP2021512143A/ja active Pending
- 2019-01-25 EP EP22214010.5A patent/EP4215520A1/en not_active Withdrawn
- 2019-01-25 FI FIEP19702958.0T patent/FI3743406T3/fi active
- 2019-01-25 TW TW108102837A patent/TWI908705B/zh active
- 2019-01-25 WO PCT/GB2019/050209 patent/WO2019145726A1/en not_active Ceased
- 2019-01-25 GB GBGB2105206.3A patent/GB202105206D0/en not_active Ceased
- 2019-01-25 PE PE2020001115A patent/PE20210657A1/es unknown
- 2019-01-25 RS RS20230225A patent/RS64073B1/sr unknown
- 2019-01-25 GB GB2108469.4A patent/GB2600512A/en not_active Withdrawn
- 2019-01-25 CA CA3086747A patent/CA3086747A1/en active Pending
- 2019-01-25 DK DK19702958.0T patent/DK3743406T3/da active
- 2019-01-25 EP EP25202575.4A patent/EP4699655A3/en active Pending
- 2019-01-25 MX MX2020007899A patent/MX2020007899A/es unknown
- 2019-01-25 ES ES19702958T patent/ES2943636T3/es active Active
- 2019-01-25 SG SG11202006067XA patent/SG11202006067XA/en unknown
- 2019-01-25 PT PT197029580T patent/PT3743406T/pt unknown
- 2019-01-25 CN CN202411465530.3A patent/CN119490451A/zh active Pending
- 2019-01-25 PL PL19702958.0T patent/PL3743406T3/pl unknown
- 2019-01-25 EP EP19702958.0A patent/EP3743406B9/en active Active
- 2019-01-25 MA MA51669A patent/MA51669B1/fr unknown
- 2019-01-25 LT LTEPPCT/GB2019/050209T patent/LT3743406T/lt unknown
- 2019-01-25 SI SI201930440T patent/SI3743406T1/sl unknown
- 2019-01-25 EA EA202091576A patent/EA202091576A1/ru unknown
- 2019-11-22 US US16/501,493 patent/US11364246B2/en active Active
-
2020
- 2020-06-25 ZA ZA2020/03856A patent/ZA202003856B/en unknown
- 2020-07-23 CL CL2020001945A patent/CL2020001945A1/es unknown
- 2020-08-25 PH PH12020551327A patent/PH12020551327A1/en unknown
- 2020-08-26 CO CONC2020/0010552A patent/CO2020010552A2/es unknown
-
2022
- 2022-05-17 US US17/663,716 patent/US12377105B2/en active Active
-
2023
- 2023-01-20 AU AU2023200327A patent/AU2023200327A1/en not_active Abandoned
- 2023-11-10 JP JP2023191935A patent/JP2024023271A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021512143A5 (enExample) | ||
| GB2583882A (en) | Compounds | |
| CN101084195B (zh) | 作为5-ht2a血清素受体调节剂适用于治疗与其相关的病症的3-苯基-吡唑衍生物 | |
| CN1428145A (zh) | 用作速激肽nk3受体拮抗剂的喹啉衍生物 | |
| US20170281649A1 (en) | Compounds and therapeutic uses | |
| RU2008136553A (ru) | Производные бензотиазола в качестве агонистов бета2 адренорецептора | |
| JP2013510883A5 (enExample) | ||
| CA2895448A1 (en) | Autotaxin inhibitors | |
| JP2013523636A5 (enExample) | ||
| JP2023544716A5 (enExample) | ||
| JP2016514711A5 (enExample) | ||
| CA2618511A1 (en) | Novel benzothiazolone derivatives | |
| NL1028599C2 (nl) | Verbindingen voor de behandeling van ziekten. | |
| RU2015114937A (ru) | Замещенные соединения карбамата и их применение в качестве антагонистов канала с транзиторным рецепторным потенциалом (trp) | |
| JP2022541311A5 (enExample) | ||
| MXPA05003105A (es) | Compuestos de amonio cuaternario. | |
| JP2022535986A5 (enExample) | ||
| JP2023507188A5 (enExample) | ||
| JP2022541638A5 (enExample) | ||
| WO2024054807A1 (en) | Combination therapies including metal channel activators and tdp-43 modulators | |
| KR20250105362A (ko) | 금속 채널 활성화제 및 nmda 수용체 길항제를 포함하는 병용 요법 | |
| KR20240127392A (ko) | 수면 무호흡의 치료를 위한 α2-아드레날린수용체 하위유형 C (알파-2C) 길항제와 무스카린성 수용체 길항제의 조합물 | |
| KR20240124995A (ko) | 수면 무호흡의 치료를 위한 a2-아드레날린수용체 하위유형 c (알파-2c) 길항제와 노르에피네프린 재흡수 억제제의 조합물 | |
| JP2023503470A5 (enExample) | ||
| EA046966B1 (ru) | Соединения |